TELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere ...

Find out more about the overall breast cancer treatment landscape, as biotech companies make progress with different ...

Researcher Shikhadri Mahanta explains the effective eco credentials of atmospheric cold plasma as a food science technique.

Imagine a world where bacteria, typically feared for causing disease, are turned into powerful weapons against cancer. That’s ...

This groundbreaking finding suggests that Telomir-1 may selectively benefit healthy cells while suppressing malignant growth, challenging the assumption that telomere-elongating drugs inherently ...

Overall, this makes rainwater everywhere – including places like sub-Saharan Africa and South and Southeast Asia, where it’s ...